Hyperliquid Tests $87 Resistance as ATH Climbs to $86.71
Hyperliquid reached $86.71 on Sept. 2, a new all-time high, before consolidating near $81. Technical analysts cite intact uptrend momentum with potential for $95 if the $87 level breaks decisively.
Written by CoinArticle’s AI Newsroom · from 3 cited sources. How we work
Story Updates
- Updated Sep 2, 2026, 02:03 PM: Hyperliquid posted a new all-time high of $86.71 on September 2; technical targets extended to $95 if $87 resistance breaks.
New All-Time High and Consolidation
Hyperliquid traded near $81 on September 2 after retreating from a fresh all-time high of $86.71, according to Crypto.news data. The token's wider uptrend remains intact despite fading short-term momentum, with the $87 level now serving as the next overhead resistance for bullish traders.
Technical Setup and Potential Targets
If HYPE breaks above $87 decisively, technical analysts flagged a potential move toward $95 as the next target. The consolidation below the recent ATH suggests profit-taking rather than a trend reversal, with on-chain activity and rising platform fees continuing to underpin the protocol's usage metrics.
Platform Activity Continues
Rising platform fees on Hyperliquid's perpetual trading protocol accompanied the price gains, indicating sustained user engagement and trading volume expansion. The combination of technical strength and measurable protocol activity has kept attention on the token as it navigates the $81-$87 range.
Why It Matters
For Traders
HYPE consolidation near $81 with defined $87 resistance offers a clear technical setup for 24-48 hour entry or exit decisions.
For Investors
Sustained platform fee growth alongside repeated all-time highs suggests organic adoption, though price discovery phase sustainability remains unproven.
For Builders
Continued protocol fee expansion during price strength indicates Hyperliquid's perpetual DEX volume is scaling; infrastructure demand appears validated.
This article is for information only and is not financial advice. Read the full disclaimer.
